Nasal vaccine or monoclonal therapy: Which is winning weapon against SARS-CoV-2 variants in 2022?
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Global Health"
DOI: 10.7189/jogh.12.03023
Abstract: the coronavirus transformations are harmless. The Alpha variant had already distinguished itself for the greater speed of contagion compared to the original SARS-CoV-2 virus; the Beta affected younger subjects, between 10 and 30 years; Gamma… read more here.
Keywords: nasal vaccine; vaccine monoclonal; winning weapon; monoclonal therapy ... See more keywords